Ginkgo biloba extracts (GBE) have been shown to be as effective as anti-cholinesterase inhibitors in improving the cognitive test scores of patients with dementia. Although it has been assumed that GBE works via its antioxidant and vascular effects, some evidence has emerged that GBE may have some pro-cholinergic activity. We wished to test the hypothesis that a standardised preparation of GBE, Li 1370, increases cholinergic activity by measuring its effect on the sleep polysomnogram. In particular, latency to Rapid Eye Movement (REM) sleep is sensitive to cholinergic activity. For this purpose we recruited 10 healthy volunteers of both sexes and recorded sleep polysomnograms in a randomised cross-over study, comparing sleep polysomnograms taken the night after a single evening dose of Li 1370 (240 mg) with sleep polysomnograms taken after an evening dose of placebo. No significant differences in sleep parameters (including REM sleep measures) were detected; however sleep efficiency measures and subjective sleep quality reports showed that Li 1370 was well tolerated.
References
-
1
Berger M, Riemann D, Hochli D, Spiegel R.
The cholinergic rapid eye movement sleep induction test with RS-86.
Arch Gen Psychiatry.
1989;
46
421-428
-
2
Berkawitz A, Sutton L, Janowsky D S, Gillin J C.
Pilocarpine, an orally active muscarinic cholinergic agonist, induces REM sleep and reduces delta sleep in normal volunteers.
Psych Res.
1990;
33
113-119
-
3
Fugh-Berman A, Cott J M.
Dietary supplements and natural products as psychotherapeutic agents.
Psychosomatic medicine.
1999;
61
712-728
-
4
Hobson J A, Lydic R, Baghdoyan H A.
Evolving concepts of sleep cycle generation: from brain centres to neuronal populations.
Behav Brain Sci.
1986;
9
371-44
-
5
Kleijnen J, Knipschild P.
Ginkgo biloba.
.
Lancet.
1992;
340
1136-1139
-
6
Kristofikova Z, Klaschka J.
In vitro effect of Gingko biloba extract (EGb 761) on activity of presynaptic cholinergic nerve terminals in rat hippocampus.
Dementia.
1997;
8
43-48
-
7 Michel P F. Chronic cerebral insufficiency and Ginkgo biloba extract. In Effects of Ginkgo biloba extract on organic cerebral impairment. Editors Agnoli, A., J.R.Rapin, V. Scapagnini, W.V. Weitbrecht. Published John Libbey Eurotext 1985
-
8
Oken B S, Storzbach D M, Kaye J A.
The efficacy of Ginkgo biloba on cognitive function in Alzheimer's disease.
Arch Neurol.
1998;
55
1409-1415
-
9 Rechtschaffen A, Kales A. A manual of standardised terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles Brain Information Service, Brain Research Institute, University of California 1968
-
10
Riemann D, Joy D, Hochli D, Lauer C, Zulley J, Berger M.
Influence of the cholinergic agonist RS 86 on normal sleep: sex and age effects.
Psychiatry Research.
1988;
24
137-146
-
11
Sharpley A L, Cowen P J.
Effect of pharmacological treatments on the sleep of depressed patients.
Biol. Psychiatry.
1995;
37
85-98
-
12
Sharpley A L, Williamson D J, Attenburrow M E J, Pearson G, Sargent P, Cowen P J.
The effects of paroxetine and nefazodone on sleep: a placebo controlled trial.
Psychopharmacology.
1996;
126
50-54
-
13
Sharpley A L, McGavin C L, Whale R, Cowen P J.
Antidepressant-like effect of Hypericum perforatum (St John's wort) on the sleep polysomnogram.
Psychopharmacology.
1998;
139
286-287
-
14
Sitarum N, Mendelson W B, Wyatt R J, Gillin J C.
The time-dependent induction of REM sleep and arousal by physostigmine infusion during normal human sleep.
Brain Res.
1977;
122
562-567
-
15
Sitarum N, Gillin J C.
Development and use of pharmacological probes of the CNS in man: Evidence for cholinergic abnormality in primary affective illness.
Biol Psychiatry.
1980;
15
925-955
-
16
Speigel R.
Effects of RS 86, an orally active cholinergic agonist, on sleep in man.
Psych Res.
1984;
11
1-13
-
17 Taylor J E. The effect of chronic, oral Ginkgo biloba extract administration on neurotransmitter receptor binding in young and aged Fisher 344 rats. Editors Agnoli, A., J.R.Rapin, V. Scapagnini, W.V. Weitbrecht. In Effects of Ginkgo biloba extract on organic cerebral impairment. Published John Libbey Eurotext 1985
Dr. A. L. Sharpley
Psychopharmacology Research Unit
Department of Psychiatry
Warneford Hospital
Oxford OX3 7JX
UK
Phone: ++44-1865 223906
Fax: ++44-1865 251 076
Email: ann.sharpley@psych.ox.ac.uk
